Skip to content

Major Drug Classes and Their Chemistry

CSIR NET medicinal chemistry: beta-lactams, sulfonamides, antivirals, anticancer agents, NSAIDs, cardiovascular and CNS drugs, and their SAR.

  • 14 min read
  • Updated
On this page · 16 sections
  1. Prerequisites
  2. The Hook: Four Membered Rings and a Century of Chemistry
  3. Antibacterial Agents
  4. Antiviral and Antifungal Agents
  5. Anticancer Agents
  6. Anti-inflammatory and Analgesic Agents
  7. Cardiovascular and Gastrointestinal Agents
  8. Central Nervous System Agents
  9. Heterocycles: Why They Are Everywhere
  10. Memory Tricks
  11. Don’t Confuse
  12. Common Mistakes
  13. Practice
  14. Quick Revision Table
  15. Key Takeaways
  16. What’s Next

Prerequisites

The Hook: Four Membered Rings and a Century of Chemistry

Antibacterial Agents

Cell-wall synthesis: β-lactams

The bicyclic penicillin core is 6-aminopenicillanic acid (β-lactam fused to a thiazolidine); cephalosporins have the β-lactam fused to a six-membered dihydrothiazine ring (7-aminocephalosporanic acid). Both acylate the active-site serine of the transpeptidase (penicillin-binding protein) that cross-links peptidoglycan.

SAR pointConsequence
Ring strain + poor amide resonancethe carbonyl is electrophilic enough to acylate serine
Free carboxylaterequired for binding; esterified penicillins are prodrugs
6-Acylamino side chainvaried to tune spectrum, acid stability and β-lactamase resistance
Electron-withdrawing side chain (phenoxymethyl)survives stomach acid — oral penicillin V
Bulky ortho-substituted aryl side chainsterically blocks β-lactamase (the methicillin-type design)
Polar group (NH\(_2\), COOH) on the side chainbroader Gram-negative spectrum (aminopenicillins, carboxypenicillins)

Resistance comes mainly from β-lactamases, which hydrolyse the ring. The chemical answer is a second molecule: clavulanic acid, sulbactam and tazobactam are β-lactamase inhibitors, clavulanate acting as a mechanism-based inactivator, given in combination with a penicillin. Other resistance routes are altered penicillin-binding proteins and efflux.

Other cell-wall agents: glycopeptides such as vancomycin, which bind the D-Ala-D-Ala substrate itself rather than the enzyme (resistance arises when the terminus changes to D-Ala-D-lactate), and cycloserine and fosfomycin, which block earlier steps.

Protein synthesis: the ribosome

ClassSubunitChemistry
Aminoglycosides (streptomycin, gentamicin)30Shighly polar aminosugars; poor oral absorption
Tetracyclines30Slinear tetracyclic, chelates divalent metals (hence interaction with Ca\(^{2+}\)/Mg\(^{2+}\))
Macrolides (erythromycin type)50Slarge lactone ring glycosylated with amino- and deoxysugars; acid-labile ketalisation is designed out in later analogues
Chloramphenicol50Snitroaromatic dichloroacetamide; peptidyl transferase inhibitor
Oxazolidinones50Sblock initiation-complex formation

Nucleic acid and folate pathways

  • Quinolones/fluoroquinolones: 4-quinolone-3-carboxylic acids inhibiting DNA gyrase and topoisomerase IV. The C-6 fluorine and C-7 amine (commonly a piperazine) are classic potency- and spectrum-determining substituents; the 3-carboxylate and 4-oxo pair is essential and also chelates metal ions.
  • Sulfonamides: structural analogues of p-aminobenzoic acid that competitively inhibit dihydropteroate synthase. The free aromatic NH\(_2\) para to the sulfonamide is required, and N\(^1\)-substitution tunes acidity and solubility. They are antimetabolites: humans do not make folate, so the pathway is absent in us.
  • Trimethoprim: a 2,4-diaminopyrimidine inhibiting bacterial dihydrofolate reductase far more tightly than the human enzyme. Combined with a sulfonamide it blocks the same pathway at two points.
  • Rifamycins: inhibit bacterial DNA-dependent RNA polymerase; note their strong enzyme-inducing effect in the host.
graph TD
    A["Folate pathway"] --> B["PABA + pteridine
dihydropteroate synthase"] B -->|"blocked by sulfonamides"| C["Dihydrofolate"] C --> D["Dihydrofolate reductase"] D -->|"blocked by trimethoprim (bacterial)
methotrexate (human, anticancer)"| E["Tetrahydrofolate"] E --> F["Thymidylate synthase
(blocked by 5-FU as FdUMP)"] F --> G["dTMP, DNA synthesis"]

Antiviral and Antifungal Agents

ClassTargetKey chemistry
Nucleoside analogues (acyclovir, zidovudine)viral polymerase / reverse transcriptaselack a free 3′-OH, so incorporation terminates the chain; acyclovir needs viral thymidine kinase for the first phosphorylation
Non-nucleoside reverse transcriptase inhibitorsallosteric pocket of RTnon-competitive; resistance arises from single pocket mutations
Protease inhibitorsviral aspartyl proteasepeptidomimetics with a non-hydrolysable transition-state isostere (hydroxyethylene, hydroxyethylamine)
Neuraminidase inhibitorsviral neuraminidasetransition-state mimics of the sialic acid oxocarbenium ion; one widely used member is an ester prodrug
Azole antifungalsfungal lanosterol 14α-demethylase (a P450)the imidazole or triazole nitrogen coordinates the haem iron; selectivity over human P450s is never perfect, hence interactions
Polyenes (amphotericin B)ergosterol in the fungal membranelarge polyene macrolactone; binds sterol and permeabilises the membrane

The azoles are the clearest case of inorganic chemistry inside a drug: a basic sp\(^2\) nitrogen of the heterocycle is the iron-binding group, and the rest of the molecule is the specificity handle.

Anticancer Agents

ClassMechanism
Alkylating agents (nitrogen mustards, nitrosoureas, busulfan)generate an aziridinium or similar electrophile; bifunctional agents cross-link DNA at N7 of guanine
Platinum complexes1,2-intrastrand cross-links; see Metal Complexes in Medicine
Antimetabolitesmethotrexate (DHFR), 5-fluorouracil (thymidylate synthase via FdUMP), purine and pyrimidine analogues
Topoisomerase poisons / intercalatorsanthracyclines, camptothecin-type and podophyllotoxin-derived agents
Antimitoticsvinca alkaloids and colchicine-site agents prevent tubulin polymerisation; taxanes stabilise microtubules
Targeted agentskinase inhibitors occupying the ATP site, usually built on a heteroaromatic hinge-binding motif

Cyclophosphamide is worth remembering as a prodrug: it is oxidised in the liver and the activated species decomposes to the DNA-alkylating mustard plus acrolein. The design point is that the administered molecule is not itself an alkylating agent.

Anti-inflammatory and Analgesic Agents

ClassTargetChemistry
Aspirincyclo-oxygenaseirreversible: the acetyl group is transferred to an active-site serine
Other NSAIDs (arylalkanoic acids, arylpropionic acids, fenamates)cyclo-oxygenasereversible, competitive; an acidic group plus a lipophilic aromatic system is the common pharmacophore
COX-2-selective agents (“coxibs”)COX-2 isoformbulky sulfone or sulfonamide group exploits a larger side pocket in COX-2
Paracetamoldistinct from classical NSAID actionmetabolically interesting (see NAPQI)
Opioid analgesicsopioid receptorsmorphinan skeleton; free phenolic OH and basic nitrogen are key — 3-O-methylation gives codeine, a prodrug; N-allyl or N-cyclopropylmethyl substitution converts agonist to antagonist (naloxone, naltrexone)
Steroidal anti-inflammatoriesnuclear glucocorticoid receptorsteroid nucleus with 11-OH and 3-keto-Δ4; fluorination at C-9 raises potency

The opioid SAR is one of the most quotable in the subject: the same skeleton gives an agonist or an antagonist depending only on the nitrogen substituent.

Cardiovascular and Gastrointestinal Agents

ClassTarget / mechanismChemistry worth knowing
β-Blockersβ-adrenoceptorsaryloxypropanolamine chain; the \( S \) enantiomer carries most of the activity; aryl group governs β\(_1\) selectivity
ACE inhibitorsangiotensin-converting enzyme (a zinc peptidase)designed around a zinc-binding group: thiol (captopril) or carboxylate (enalaprilat, given as the ester prodrug enalapril)
Dihydropyridine Ca\(^{2+}\)-channel blockersL-type calcium channel1,4-dihydropyridine from a Hantzsch-type synthesis; a 4-aryl group is essential
StatinsHMG-CoA reductasedihydroxy-acid (or lactone prodrug) mimicking the reaction intermediate
Nitratesnitric-oxide donorsorganic nitrate esters releasing NO, a vasodilator signalling molecule
H\(_2\) antagonistshistamine H\(_2\) receptorthe classic rational-design story: an imidazole-containing lead with a polar, non-basic side chain, later analogues replacing the imidazole by furan or thiazole
Proton-pump inhibitorsgastric H\(^+\)/K\(^+\)-ATPaseacid-activated prodrug: the benzimidazole sulfoxide cyclises to a sulfenamide that forms a disulfide with an enzyme cysteine

Central Nervous System Agents

ClassMechanism in one line
Benzodiazepinespositive allosteric modulators at the GABA\(_A\) receptor
Barbituratesact at the same receptor complex, with a different and less forgiving margin
Tricyclic and SSRI antidepressantsblock monoamine (serotonin/noradrenaline) reuptake transporters
Monoamine oxidase inhibitorsblock oxidative deamination of monoamines
Typical/atypical antipsychoticsdopamine D\(_2\) (and, for the atypicals, additional serotonin receptor) antagonism
Levodopaprodrug of dopamine, carried across the blood–brain barrier by an amino-acid transporter
Local anaestheticsblock voltage-gated Na\(^+\) channels; ester-linked members are hydrolysed quickly, amide-linked ones last longer

CNS activity imposes its own physicochemical rules: lower molecular mass, fewer hydrogen-bond donors and a smaller polar surface area than a typical oral drug, because the blood–brain barrier is far less permissive than the gut wall.

Heterocycles: Why They Are Everywhere

RingWhy medicinal chemists use it
Pyridinebasic but not protonated at pH 7.4, lowers \( \log P \), good acceptor
Imidazole / triazolemetal binder (azoles at haem iron), acceptor and donor
Piperazine, morpholinesolubilising basic groups, easy to attach
Indoleprivileged scaffold from tryptophan-derived biology
Pyrimidine / purinenucleic-acid mimicry (antimetabolites, kinase hinge binders)
Tetrazolecarboxylic-acid bioisostere
Thiophene, furanphenyl replacements with different metabolic liabilities (be alert to oxidation to reactive species)

Heterocycles let a chemist tune \( pK_a \), solubility, metabolic stability and hydrogen-bonding pattern while keeping shape — the practical face of bioisosterism.

Memory Tricks

Don’t Confuse

ThisvsThat
Penicillins (thiazolidine-fused)Cephalosporins (dihydrothiazine-fused)
β-Lactamase inhibitor (clavulanate)β-Lactam antibiotic (amoxicillin) — the combination needs both
Vancomycin (binds the substrate D-Ala-D-Ala)Penicillin (acylates the enzyme)
Sulfonamide antibacterial (PABA antimetabolite)Sulfonylurea or other sulfonamide-containing drugs with unrelated targets
Trimethoprim (bacterial DHFR)Methotrexate (human DHFR, anticancer)
Aspirin (irreversible COX acetylation)Other NSAIDs (reversible, competitive)
Vinca alkaloids (block polymerisation)Taxanes (stabilise microtubules)
Codeine (3-O-methyl prodrug)Naloxone (N-substituted antagonist)

Common Mistakes

Practice

All questions below are original practice questions written for this page. They are not from any CSIR NET paper.

Level 1: Foundation

  1. Which enzyme do sulfonamides inhibit, and which metabolite do they mimic?
  2. What structural change converts an opioid agonist into an antagonist?
  3. Name the ribosomal subunit targeted by tetracyclines.
Answers
  1. Dihydropteroate synthase; they mimic p-aminobenzoic acid (PABA).
  2. Replacing the N-methyl by N-allyl or N-cyclopropylmethyl (naloxone, naltrexone).
  3. The 30S subunit.

Level 2: Part B Style

Practice Q1. Vancomycin differs mechanistically from penicillin in that it:

(a) inhibits the 50S subunit (b) binds the D-Ala-D-Ala peptide terminus rather than the transpeptidase (c) is a β-lactamase inhibitor (d) blocks DNA gyrase

Answer: (b)

Vancomycin sequesters the substrate; penicillin acylates the enzyme. This is also why resistance to vancomycin arises by changing the terminus to D-Ala-D-lactate.

Practice Q2. Azole antifungals act by:

(a) binding ergosterol directly (b) coordinating the haem iron of lanosterol 14α-demethylase (c) inhibiting the 30S ribosomal subunit (d) cross-linking fungal DNA

Answer: (b)

A basic ring nitrogen of the imidazole or triazole coordinates the P450 haem iron. Option (a) describes the polyenes such as amphotericin B.

Practice Q3. Which pair acts at two consecutive steps of the same pathway?

(a) Aspirin and paracetamol (b) Sulfamethoxazole and trimethoprim (c) Vincristine and paclitaxel (d) Acyclovir and zidovudine

Answer: (b)

The sulfonamide blocks dihydropteroate synthase and trimethoprim the bacterial dihydrofolate reductase — sequential blockade of folate synthesis.

Practice Q4. The acid stability of penicillin V relative to penicillin G is attributed to:

(a) the free carboxylate (b) an electron-withdrawing phenoxymethyl side chain that disfavours side-chain participation in ring opening (c) the thiazolidine sulfur (d) a larger β-lactam ring

Answer: (b)

An electron-withdrawing group on the side chain reduces neighbouring-group participation by the side-chain amide in acid-catalysed opening of the β-lactam, so the oral route becomes practical. The carboxylate and the thiazolidine are common to both.

Level 3: Part C Style

Practice Q5. A bacterial strain is resistant to amoxicillin but susceptible to amoxicillin + clavulanate. A second strain is resistant to both. Which statements are consistent?

  1. The first strain most likely produces a β-lactamase that clavulanate inactivates.
  2. The second strain’s resistance may involve an altered penicillin-binding protein.
  3. The second strain’s resistance may involve a β-lactamase not inhibited by clavulanate.
  4. Clavulanate restores activity because it is itself a potent antibacterial.

(a) 1, 2 and 3 only (b) 1 and 4 only (c) 2, 3 and 4 only (d) 1, 2, 3 and 4

Answer: (a) 1, 2 and 3 only

1–3 are the standard resistance routes (enzymatic hydrolysis, target alteration, an enzyme outside the inhibitor’s spectrum; efflux is a fourth). 4 is wrong: clavulanate’s contribution is protection of the partner β-lactam, not intrinsic potency.

Practice Q6. Consider four agents: (i) methotrexate, (ii) 5-fluorouracil, (iii) cyclophosphamide, (iv) paclitaxel. Which statements are correct?

  1. (i) is a competitive inhibitor of dihydrofolate reductase.
  2. (ii) must be converted to FdUMP before it inhibits thymidylate synthase.
  3. (iii) is a prodrug requiring hepatic oxidation before it can alkylate DNA.
  4. (iv) prevents tubulin polymerisation.

(a) 1, 2 and 3 only (b) 1, 3 and 4 only (c) 2, 3 and 4 only (d) 1, 2, 3 and 4

Answer: (a) 1, 2 and 3 only
  1. Methotrexate is a folate analogue competing at the DHFR folate site. Correct.
  2. The nucleotide FdUMP is the species that traps thymidylate synthase. Correct.
  3. Cyclophosphamide is activated by hepatic oxidation; the mustard is released downstream. Correct.
  4. Taxanes stabilise microtubules; the vinca alkaloids prevent polymerisation. Wrong.

Practice Q7. A new quinolone analogue is prepared. Which structural statements are consistent with the known SAR of the class?

  1. Removing the 3-carboxylic acid abolishes activity.
  2. A fluorine at C-6 generally increases potency.
  3. A nitrogen heterocycle such as piperazine at C-7 influences spectrum and pharmacokinetics.
  4. The drug acts by inhibiting bacterial RNA polymerase.

(a) 1, 2 and 3 only (b) 1, 2, 3 and 4 (c) 2 and 4 only (d) 1 and 4 only

Answer: (a) 1, 2 and 3 only

The 3-carboxy/4-oxo pair is essential (it also chelates metal ions, which explains why di- and trivalent cations reduce absorption); C-6 fluorine and a C-7 amine are the classic potency and spectrum handles. The target is DNA gyrase/topoisomerase IV, not RNA polymerase (that is the rifamycins). 4 wrong.

Quick Revision Table

ClassTargetRemember
β-Lactamstranspeptidase (PBP)strained ring acylates serine; clavulanate guards against β-lactamase
GlycopeptidesD-Ala-D-Ala substratebinds substrate, not enzyme
Aminoglycosides, tetracyclines30Spolar; tetracyclines chelate metals
Macrolides, chloramphenicol, oxazolidinones50Slarge lactone / nitroaromatic / initiation block
QuinolonesDNA gyrase, topo IV3-COOH + 4-oxo essential; C-6 F, C-7 amine
Sulfonamidesdihydropteroate synthasePABA antimetabolite; free para NH\(_2\)
Trimethoprim / methotrexatebacterial / human DHFRselectivity by enzyme difference
Nucleoside antiviralsviral polymerase, RTchain termination; acyclovir needs viral TK
HIV protease inhibitorsaspartyl proteasetransition-state isostere
Azoles / polyenes14α-demethylase / ergosteroliron coordination / membrane permeabilisation
Alkylators, Pt, antimetabolites, topo poisons, antimitoticsDNA and mitosisvinca destabilises, taxane stabilises
Aspirin / NSAIDs / coxibsCOXirreversible acetylation vs reversible; COX-2 side pocket
Opioidsopioid receptorsN-substituent decides agonist or antagonist
β-Blockers, ACE inhibitors, dihydropyridines, statins, PPIscardiovascular / GIzinc-binding group, 1,4-DHP core, acid-activated sulfenamide

Key Takeaways

What’s Next

Advertisement
Advertisement